Is Deltagen Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Deltagen Inc (DGEN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Deltagen Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Deltagen Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Deltagen Inc?

Muslim investors may consider investing in Deltagen Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Deltagen Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Deltagen Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Deltagen Inc updated?

The Shariah compliance status of Deltagen Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Deltagen Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Deltagen Inc?

You can check the latest Shariah compliance status of Deltagen Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Deltagen Inc. Stock Analysis DGEN

United States N/A Nano Cap

Deltagen, Inc. engages in the provision of drug discovery tools and services to the biopharmaceutical industry. The company is headquartered in San Carlos, California. The company went IPO on 2000-08-03. The firm offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The firm's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.

Financial Metrics & Statements of Deltagen Inc (DGEN)

FAQ's for Deltagen Inc (DGEN)

According to Musaffa’s Shariah screening methodology, Deltagen Inc (DGEN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.